Loading clinical trials...
Loading clinical trials...
A Phase 3 Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy Incorporating a Randomized Assessment of Sodium Thiosulfate as Otoprotection for Children With Localized Disease, and Response Adapted Therapy for Patients With Metastatic Disease
Conditions
Interventions
Sodium Thiosulfate Injection
Primary surgery resection
+9 more
Locations
1
China
Shanghai Children's Medical Center
Shanghai, Shanghai Municipality, China
Start Date
March 1, 2021
Primary Completion Date
March 31, 2026
Completion Date
September 30, 2027
Last Updated
May 18, 2025
NCT04308330
NCT04851119
NCT07148050
NCT07300449
NCT03959800
NCT03155620
Lead Sponsor
Shanghai Children's Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions